Skip to main content
All lobbying filings

CGCN GROUP, LLC

CGCN GROUP, LLC filed a Q2 report for PARTNER THERAPEUTICS, INC. on July 19, 2026, reporting $80,000 in lobbying income.

Lobbying for PARTNER THERAPEUTICS, INC. · Biopharmaceutical company

All filings by CGCN GROUP, LLC · Everything PARTNER THERAPEUTICS, INC. has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 19, 2026
Income
$80,000
What the client paid this registrant for the period.
Client based in
Massachusetts

Official filing document

 Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Issues pertaining to the development of public health emergency medical countermeasures. Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act.

Issues related to medical countermeasures for Acute Radiation Syndrome (ARS).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem